Company name
2022Founder
Sek Kathiresan MD leads Verve Therapeutics as its founder and CEO, developing gene-editing medicines intended to lower cholesterol and prevent cardiovascular disease. He previously directed genomic medicine research at Massachusetts General Hospital and cardiovascular disease research at the Broad Institute, and served as a professor at Harvard Medical School. His work has linked human genetics to cardiovascular risk and potential treatment targets.
Chief Executive Officer, Founder
Senior Vice President
Principal Investigator
Doctor of Medicine
Bachelor of Arts in History
Cosign details are not available yet.
More profile details are not available yet.